APA (7th ed.) Citation

Saleh, K., Daste, A., Martin, N., Pons-Tostivint, E., Auperin, A., Herrera-Gomez, R. G., . . . Even, C. (2019). Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. European Journal of Cancer, 121, 123. https://doi.org/10.1016/j.ejca.2019.08.026

Chicago Style (17th ed.) Citation

Saleh, Khalil, et al. "Response to Salvage Chemotherapy After Progression on Immune Checkpoint Inhibitors in Patients with Recurrent And/or Metastatic Squamous Cell Carcinoma of the Head and Neck." European Journal of Cancer 121 (2019): 123. https://doi.org/10.1016/j.ejca.2019.08.026.

MLA (9th ed.) Citation

Saleh, Khalil, et al. "Response to Salvage Chemotherapy After Progression on Immune Checkpoint Inhibitors in Patients with Recurrent And/or Metastatic Squamous Cell Carcinoma of the Head and Neck." European Journal of Cancer, vol. 121, 2019, p. 123, https://doi.org/10.1016/j.ejca.2019.08.026.